A phase IIIb study to evaluate the efficacy and time course of treatment with SPD465 [amfetamine mixed salts; adderall] compared to placebo on simulated driving safety and performance in adults with attention-deficit hyperactivity disorder (ADHD)

Trial Profile

A phase IIIb study to evaluate the efficacy and time course of treatment with SPD465 [amfetamine mixed salts; adderall] compared to placebo on simulated driving safety and performance in adults with attention-deficit hyperactivity disorder (ADHD)

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Mixed amfetamine salts (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Sponsors Shire
  • Most Recent Events

    • 16 Jul 2007 Status changed from initiated to withdrawn prior to recruitment.
    • 18 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top